Physician profile
Michael E Pichichero
NPI 1245337047
$168,155.17
in general payments reported to CMS, 2019-2025
10 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $5,024 · 2021: $29K · 2022: $20K · 2023: $7,677 · 2024: $38K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $80K · Travel and Lodging: $18K · Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,725.00 |
| Travel and Lodging | $18,477.73 |
| Food and Beverage | $316.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $95,310.08 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $20,613.88 | 2019-2025 | |
| Pfizer INC. | $17,433.06 | 2021-2022 | |
| Modernatx, INC. | $14,350.38 | 2021-2022 | |
| Sanofi Pasteur INC. | $11,559.82 | 2019-2022 | |
| Eli Lilly and Company | $5,238.68 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $3,000.00 | 2023 | |
| Photonicare INC | $450.00 | 2022 | |
| Henry Schein, INC. | $199.27 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pichichero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.